News

Hosted on MSN3m
Novo Nordisk’s CagriSema Shot Tied to Greater Weight Loss at Lower Doses
The company is also testing CagriSema head-to-head with Eli Lilly & Co.’s Zepbound, the obesity drug that’s currently winning ...